МНЕНИЕ

Лекарственные системы на основе поли-3-оксиалканоатов: их микро- и наноструктура

А. П. Бонарцев1,2, Г. А. Бонарцева2, В. В. Воинова1, М. П. Кирпичников1, К. В. Шайтан1
Информация об авторах

1 Биологический факультет, Московский государственный университет имени М. В. Ломоносова, Москва

2 Институт биохимии имени А. Н. Баха, ФИЦ Биотехнологии РАН, Москва

Для корреспонденции: Антон Павлович Бонарцев
Ленинские горы, д. 1, стр. 12, г. Москва, 119234; ur.liam@ranob_tna

Информация о статье

Финансирование: работа поддержана грантом РНФ, проект № 17-74-20104 в рамках раздела 1 и грантом РФФИ офи_м,
проект № 15-29-04856 в рамках раздела 2.

Статья получена: 26.08.2018 Статья принята к печати: 22.09.2018 Опубликовано online: 30.12.2018
|
  1. Bonartsev AP. Poly(3-hydroxybutyrate): applications. In: Mishra M, editor. Encyclopedia of Polymer Applications. Boca Raton: CRC Press, Taylor and Francis Group, 2019; 5250 p. DOI: 10.1201/9781351019422-140000085.
  2. Bonartsev AP, Voinova VV, Bonartseva GA. Poly(3-hydroxybutyrate) and human microbiota. Applied biochemistry and microbiology. 2018; 54 (6): 547–68. DOI: 10.1134/S0003683818060066.
  3. Lee TH, Wang J, Wang CH. Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies. J Control Release. 2002; (83): 437–52.
  4. Dong Y, Feng SS. Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005; (26): 6068–76.
  5. Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S et al. Targeted nanoparticles for cancer therapy. Nano Today. 2007; (2): 14–21.
  6. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis Adv Drug Deliv Rev. 2002; (54): 631–51.
  7. Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DM, Boothman DA, Gao J. β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release. 2007; (122): 365–74.
  8. Nguyen A, Marsaud V, Bouclier C, Top S, Vessieres A, Pigeon P, Gref R, Legrand P, Jaouen G, Renoir JM. Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment. Int J Pharm. 2008; (347): 128–35.
  9. Iwata T et al. Enzymatic Degradation and Adsorption on Poly[(R)- 3-hydroxybutyrate] Single Crystals with Two Types of Extracellular PHB Depolymerases from Comamonas acidovorans YM1609 and Alcaligenes faecalis T1. Macromolecules. 1997; 97 (30): 5290–6.
  10. Capitán MJ, Rueda DR, Ezquerra TA. Inhibition of the crystallization in nanofilms of poly(3-hydroxybutyrate). Macromolecules. 2004; 15 (37): 5653–9.
  11. Liu YX, Chen EQ. Polymer crystallization of ultrathin films on solid substrates. Coordination Chemistry Reviews. 2010; 254 (9–10): 1011–37.
  12. Barnard GN, Sanders JK. J Biol Chem. 1989; 264 (6): 3286–91.
  13. Harrison ST, Chase HA, Amor SR, Bonthrone KM, Sanders JK. Plasticization of poly(hydroxybutyrate) in vivo. Int J Biol Macromol. 1992; 14 (1): 50–6.
  14. Lauzier C, Revol JF, Marchessault RH. FEMS Microbiol Rev. 1992; (103): 299–310.
  15. Sudesh K, Abe H, Doi Y. Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters. Prog Polym Sci. 2000; (25): 1503–55.
  16. Abe H, Doi Y. Structural effects on enzymatic degradability for poly[(R )-3-hydroxybutyric acid] and its copolymers: mini-review. Int J Biol Macromol. 1999; (25): 185–92.
  17. Schliecker G, Schmidt C, Fuchs S, Wombacher R, Kissel T. Hydrolytic degradation of poly(lactide-co-glycolide) films: effect of oligomers on degradation rate and crystallinity. Int J Pharm. 2003; 266 (1–2): 39-49.
  18. Kunze C, Edgar Bernd H, Androsch R, Nischan C, Freier T, Kramer S, Kramp B, Schmitz KP. In vitro and in vivo studies on blends of isotactic and atactic poly (3-hydroxybutyrate) for development of a dura substitute material. Biomaterials. 2006; 27 (2): 192–201.
  19. Жуйков В. А. Исследование изменений физико-химических свойств поли-3-оксибутирата и его сополимеров в процессе биодеградации in vitro [диссертация]. М.: 2018